UK Markets close in 8 hrs 24 mins

Neurocrine Biosciences, Inc. (0K6R.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
86.33+1.82 (+2.15%)
As of 05:58PM BST. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    Neurocrine Biosciences (NBIX) Q1 2022 Earnings Call Transcript

    With me as usual are Kevin Gorman, our chief executive officer; Matt Abernethy, our chief financial officer; Eiry Roberts, our chief medical officer; Eric Benevich, our chief commercial officer; and Kyle Gano, our chief business development and strategy officer. Before we get going, I'll remind everyone that during today's call, we will be making forward-looking statements.

  • Zacks

    Neurocrine Biosciences (NBIX) Lags Q1 Earnings Estimates

    Neurocrine (NBIX) delivered earnings and revenue surprises of -57.58% and 1.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Simply Wall St.

    Is Neurocrine Biosciences (NASDAQ:NBIX) A Risky Investment?

    David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...